Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.46 |
| ▸ | ITGAL | P20701 | 19/20 | 0.44 |
| ▸ | ITGB2 | P05107 | 18/20 | 0.44 |
| ▸ | ICAM1 | P05362 | 18/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10277544 | 0.93 | TMEM97 (0.56) | TMEM97ITGALITGB2ICAM1 | |
| SCHEMBL10277543 | 0.93 | TMEM97 (0.56) | TMEM97ITGALITGB2ICAM1 | |
| SCHEMBL10311751 | 0.91 | TMEM97 (0.49) | TMEM97ITGALITGB2ICAM1 | |
| SCHEMBL12310653 | 0.87 | TMEM97 (0.46) | TMEM97ITGALITGB2ICAM1 | |
| SCHEMBL10311754 | 0.87 | TMEM97 (0.49) | TMEM97ITGALITGB2ICAM1 | |
| SCHEMBL13804437 | 0.84 | ITGB2 (0.53) | TMEM97ITGALITGB2ICAM1 | |
| SCHEMBL13804435 | 0.83 | ITGAL (0.55) | TMEM97ITGALITGB2ICAM1 | |
| SCHEMBL12975780 | 0.82 | TMEM97 (0.34) | TMEM97 | |
| SCHEMBL13804192 | 0.82 | ITGAL (0.51) | TMEM97ITGALITGB2ICAM1 | |
| SCHEMBL10277689 | 0.81 | TMEM97 (0.47) | TMEM97ITGALITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120178734-A1 | DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178734-A1 | DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES | ARG1, COL14A1, HPGDS | TMEM97 3752/4885ITGAL 90/4885ITGB2 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.